GBA1 and Parkinson disease: In addition to the observed decrease in GCase activity in PD patients with mutations in GBA1 [6], several publications have independently reported decreased GCase activity in animal models harboring GBA1 mutations [10, 17, 18, 21, 39], including the GBA1 D409V mutation.